当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
Glassia, Alpha-1-Proteinase Inhibitor (Human)
药品名称
Glassia, Alpha-1-Proteinase Inhibitor (Human)
承诺描述
Conduct a postmarketing clinical program for GLASSIA Investigating the Safety and Efficacy of GLASSIA vs. Placebo and another (Higher) dose of GLASSIA I.V. by Weekly Administration in Alpha1-Antitrypsin Deficient Patients with emphysema and design and conduct a fully statistically powered efficacy study for augmentation therapy with Alpha-1-Proteinase Inhibitor (Human).
承诺状态描述
The study completion date has passed and the study has not yet been completed. The final report due date has passed with no final report received.